US › Healthcare

Elevai Labs, Inc. Common Stock (ELAB)

US · Healthcare · Biotechnology

$0.98+7.85%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$681,994

Revenue YoY

+347.6%

Net profit

$-5.0M

Profit YoY

-208.8%

EPS

$-11.17

Net margin

-728.3%

Key statistics

Market cap

$4.2M

Forward P/E

0.0

P/B

0.34

Book value

$6.51

EPS (TTM)

$-150.06

52-week high

$267.12

52-week low

$0.84

50-day MA

$1.32

200-day MA

$36.71

Beta

-0.24

Shareholding

Insiders

9.99%

Institutions

1.92%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	0.70%
Morgan Stanley - Brokerage Accounts	0.33%
Schonfeld Strategic Advisors LLC	0.33%
IFP Advisors, LLC	0.04%
UBS Group AG	0.03%
Tower Research Capital LLC	0.00%
Bank of America Corp	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Elevai Labs, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.